Immediate Impact
2 from Science/Nature 68 standout
Citing Papers
Latest advances in hepatocellular carcinoma management and prevention through advanced technologies
2024 Standout
Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes
2024 Standout
Works of Maria Lamar being referenced
Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma
2017
Tivantinib (ARQ 197) versus placebo in patients (Pts) with hepatocellular carcinoma (HCC) who failed one systemic therapy: Results of a randomized controlled phase II trial (RCT).
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Maria Lamar | 252 | 60 | 99 | 113 | 16 | 323 | |
| Qing Chen | 220 | 58 | 102 | 63 | 14 | 356 | |
| Jinglong Chen | 192 | 56 | 83 | 66 | 19 | 329 | |
| Annette Baumhauer | 297 | 51 | 93 | 170 | 9 | 344 | |
| Silvija Kraljevic | 154 | 141 | 176 | 83 | 15 | 321 | |
| Jayne Gurtler | 119 | 97 | 185 | 82 | 14 | 329 | |
| Luca Ielasi | 223 | 90 | 98 | 79 | 23 | 353 | |
| Fuxi Huang | 223 | 86 | 67 | 104 | 12 | 303 | |
| Ying Liu | 194 | 58 | 79 | 51 | 24 | 305 | |
| Shinsuke Kira | 205 | 49 | 79 | 72 | 15 | 342 | |
| Shao‐Liang Zhu | 267 | 54 | 46 | 73 | 18 | 342 |
All Works
Loading papers...